![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](bg2185contents.gif)
Acta Cryst. (2008). E64, o983-o984 [ doi:10.1107/S1600536808012531 ]
Abstract: The title compound, C17H14Cl2N2O2S2, and the 3-methoxyanilino analogue reported in the preceding paper have been used as starting materials to develop benzothiazine derivatives with antimalarial activity. The molecule displays an E (trans) configuration about the central double bond. Due to conjugation in the C=C-C
N group, the putative single bond shows a significant shortening [1.418 (3) Å]. The molecule has a six-membered ring involving an intramolecular N-H
O(sulfonyl) bond, which is an example of resonance-assisted hydrogen bonding. In the crystal structure, bonds of the C-H
O(sulfonyl) and C-H
N(cyano) types form double layers of molecules parallel to (
01). Within these layers there are
-
interactions between benzene rings of pairs of centrosymmetrically related molecules, with distances of 3.7969 (12) Å between centroids. C-H
interactions are also present.
Online 3 May 2008
Copyright © International Union of Crystallography
IUCr Webmaster